• FDA Panel Recommends 2 RSV Vaccines for Older Adults

    24 days ago - By New York Times

    The shots, if approved by the agency, would be the first vaccines publicly available against a respiratory virus that kills thousands a year. Some advisers did cite a small but identifiable health risk.
    Read more ...


  • FDA Panel Narrowly Backs Pfizer RSV Vaccine for Older Adults

    24 days ago - By Time

    WASHINGTON - Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV.
    The Food and Drug Administration panel voted 7-4 on two separate questions of whether Pfizer's data showed the vaccine was safe and effective against the respiratory virus for people 60 and older. One panelist abstained from voting. The recommendation is non-binding and the FDA will make its own decision on the vaccine in the coming months.
    The positive vote came despite concerns about...
    Read more ...